These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25296164)

  • 81. Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable?
    Sanches BCF; Lalli AL; Azal Neto W; Billis A; Reis LO
    World J Urol; 2018 Jul; 36(7):1055-1058. PubMed ID: 29497860
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens.
    Djavan B; Kadesky K; Klopukh B; Marberger M; Roehrborn CG
    Eur Urol; 1998; 33(3):261-70. PubMed ID: 9555550
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.
    Shipitsin M; Small C; Choudhury S; Giladi E; Friedlander S; Nardone J; Hussain S; Hurley AD; Ernst C; Huang YE; Chang H; Nifong TP; Rimm DL; Dunyak J; Loda M; Berman DM; Blume-Jensen P
    Br J Cancer; 2014 Sep; 111(6):1201-12. PubMed ID: 25032733
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
    Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
    Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
    Mansouri N; Msakni I; Gargouri F; Khiari R; Bouziani A; Laabidi B
    Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
    [TBL] [Abstract][Full Text] [Related]  

  • 86. How accurate is our clinical prediction of "minimal prostate cancer"?
    Leibovici D; Shikanov S; Gofrit ON; Zagaja GP; Shilo Y; Shalhav AL
    Isr Med Assoc J; 2013 Jul; 15(7):359-63. PubMed ID: 23943981
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
    Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
    Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recent advances in prostate cancer pathology: Gleason grading and beyond.
    Shah RB; Zhou M
    Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
    Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
    Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?
    Feuer Z; Meng X; Rosenkrantz AB; Kasivisvanathan V; Moore CM; Huang R; Deng FM; Lepor H; Wysock JS; Huang WC; Taneja SS
    J Urol; 2021 Mar; 205(3):740-747. PubMed ID: 33026927
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Establishment of a prognostic risk model for prostate cancer based on Gleason grading and cuprotosis related genes.
    Wang H; Xie M; Zhao Y; Zhang Y
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):376. PubMed ID: 39085482
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Detection of COX-2 in liquid biopsy of patients with prostate cancer.
    Pereira VS; Alves BDCA; Waisberg J; Fonseca F; Gehrke F
    J Clin Pathol; 2023 Mar; 76(3):189-193. PubMed ID: 34782424
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
    Kuhl V; Clegg W; Meek S; Lenz L; Flake DD; Ronan T; Kornilov M; Horsch D; Scheer M; Farber D; Zalaznick H; Cussenot O; Compérat E; Cancel-Tassin G; Wild PJ; Chun FK; Mandel P; Moinfar F; Cohen T; Delee S; Kronenwett R; Doedt J
    Biomark Med; 2022 Apr; 16(6):449-459. PubMed ID: 35321552
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathology in prostate research: optimizing tissue quality.
    Berney DM; Montironi R; Egevad L
    Acta Oncol; 2011 Jun; 50 Suppl 1():53-5. PubMed ID: 21604941
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Core needle biopsy wash as a tool for acquiring additional diagnostic material for laboratory testing.
    Mojica W; Cwiklinski K; Jin X; Liu W; Yergeau D
    J Clin Pathol; 2022 May; 75(5):345-349. PubMed ID: 33649141
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Modernizing the diagnostic and decision-making pathway for prostate cancer.
    Polascik TJ; Passoni NM; Villers A; Choyke PL
    Clin Cancer Res; 2014 Dec; 20(24):6254-7. PubMed ID: 25316814
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
    Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
    Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
    James ND; Spears MR; Clarke NW; Dearnaley DP; De Bono JS; Gale J; Hetherington J; Hoskin PJ; Jones RJ; Laing R; Lester JF; McLaren D; Parker CC; Parmar MKB; Ritchie AWS; Russell JM; Strebel RT; Thalmann GN; Mason MD; Sydes MR
    Eur Urol; 2015 Jun; 67(6):1028-1038. PubMed ID: 25301760
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.